Phase 1 trial of vorolanib (CM082) in combination with everolimus in patients with advanced clear-cell renal cell carcinoma-Reference-Cited by-同舟云学术

Phase 1 trial of vorolanib (CM082) in combination with everolimus in patients with advanced clear-cell renal cell carcinoma

Published:2020-05 Issue: Volume:55 Page:102755
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Sheng Xinan,Yan Xieqiao,Chi Zhihong,Cui Chuanliang,Si Lu,Tang Bixia,Li Siming,Mao Lili,Lian Bin,Wang Xuan,Bai Xue,Zhou Li,Kong Yan,Dai Jie,Ding Lieming,Mao Li,Guo Jun

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference54 articles.

1. Treatment of renal cell carcinoma: current status and future directions;Barata;CA Cancer J Clin,2017

2. Systemic therapy for metastatic renal-cell carcinoma;Choueiri;N Engl J Med,2017

3. Improved identification of von Hippel–Lindau gene alterations in clear cell renal tumors;Nickerson;Clin Cancer Res,2008

4. Identification of the von Hippel–Lindau disease tumor suppressor gene;Latif;Science,1993

5. Role of VHL gene mutation in human cancer;Kim;J Clin Oncol,2004

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-like properties of tyrosine kinase inhibitors in ophthalmology: Formulation and topical availability;International Journal of Pharmaceutics;2024-04

2. Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration;Journal of Translational Medicine;2023-02-21

3. Efficacy and safety of vorolanib plus everolimus in metastatic renal cell carcinoma: A three-arm, randomised, double-blind, multicentre phase III study (CONCEPT);European Journal of Cancer;2023-01

4. Novel Targets in Development for Advanced Renal Cell Carcinoma;Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma;2023

5. Discovery and Anticancer Activity of Novel 1,3,4-Thiadiazole- and Aziridine-Based Indolin-2-ones via In Silico Design Followed by Supramolecular Green Synthesis;ACS Omega;2022-05-12